Back to search

Article

Genetic inhibition of <i>PCSK9</i> , atherogenic lipoprotein concentrations, and calcific aortic valve stenosis

2019-03-01

Abstract excerpt

<h4>Background</h4> Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition reduces plasma concentrations of low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (apoB) and lipoprotein(a) [Lp(a)]. Atherogenic lipoprotein levels have been linked with calcific aortic valve stenosis (CAVS). Our objectives were to determine the association between variants in PCSK9 and lipoprotein-lipid levels, cor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e45711a8-8a76-531e-bfde-1c0b1f8f0c2d
DOI
10.1101/560458
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genetic inhibition of <i>PCSK9</i> , atherogenic lipoprotein concentrations, and calcific aortic valve stenosisDOI 10.1101/560458
Select a neighboring publication to make it the new centre.